Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study.
Erin A KeltyMilica OgnjenovicWarren David RaymondCharles A InderjeethHelen Isobel KeenDavid B PreenJohannes Cornelis NossentPublished in: The Journal of rheumatology (2022)
The presence of comorbidities, EAMs, and smoking contributes to an increased risk of all-cause mortality among patients with AS who are hospitalized compared to patients in the comparison group. These results support the need to prevent or reduce the occurrence of comorbidities and smoking in patients with AS.
Keyphrases
- ankylosing spondylitis
- end stage renal disease
- newly diagnosed
- smoking cessation
- ejection fraction
- chronic kidney disease
- risk assessment
- disease activity
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- risk factors
- coronary artery disease
- systemic lupus erythematosus
- patient reported outcomes
- patient reported